Last verified: April 2026. Regulatory status and clinical references were verified via MHLW records, manufacturer announcements, and peer-reviewed literature. Always confirm product details directly with your clinic.

If you have looked at Botox prices in Tokyo, you have probably noticed a confusing gap: some clinics charge ¥3,500 per area, while others charge ¥20,000 or more. The difference is almost always the brand. Budget clinics use Korean-manufactured botulinum toxins. Premium clinics use Allergan Botox Vista, the only brand approved by Japan's health ministry. Both are legal. Both are real. But they are not the same product.

This guide explains what the difference actually means — and what it does not — so you can make an informed decision before booking. For clinic-specific pricing, see our guide to English-speaking Botox clinics in Tokyo.

What Is Allergan Botox Vista?

Botox Vista is Allergan's (now AbbVie's) botulinum toxin type A, approved by Japan's Ministry of Health, Labour and Welfare for cosmetic treatment of frown lines and crow's feet. It is the only botulinum toxin with MHLW approval for cosmetic use in Japan. It is manufactured in the US and is the same core product sold globally as "Botox Cosmetic."

MHLW approval means the product has undergone Japanese regulatory review, including local clinical trials. If an adverse event occurs, there is a clear liability pathway through the manufacturer.

In Tokyo, Allergan Botox Vista typically costs ¥15,000–35,000 per area at English-speaking clinics, depending on location and whether a treatment fee is added.

What Are Korean Botulinum Toxins?

Several Korean-manufactured botulinum toxins are widely used in Japanese aesthetic clinics:

Nabota (ナボタ) (Daewoong Pharmaceutical) is the most established alternative. It is also sold as Jeuveau in the US, where it holds FDA approval. In published clinical studies, Nabota demonstrated comparable efficacy to Allergan Botox, with some evidence of faster onset.

Coretox (コアトックス) (Medytox) uses a different formulation — it contains only the core neurotoxin, stabilized with polysorbate rather than human serum albumin. This is marketed as reducing the risk of antibody formation, though long-term comparative data is limited.

Botulax (ボトラックス) (Hugel) and Innotox (イノトックス) (Medytox, liquid form) are also available at some clinics.

Knowing these names in Japanese is useful when reading Japanese clinic websites or confirming with reception staff which product is being used.

None of these brands are MHLW-approved for cosmetic use in Japan. However, Japanese physicians can legally import and use them under their own medical responsibility. This is standard practice in Japan — not a regulatory loophole or a sign that something is wrong. It does mean, however, that the manufacturer liability protections that come with MHLW approval do not apply.

Korean brands are cheaper because of lower manufacturing costs and because they have not undergone the expensive MHLW approval process in Japan. When a clinic advertises Botox at ¥3,500–8,000 per area, it is almost certainly using a Korean product.

Is There a Real Clinical Difference?

Honestly, the evidence is more nuanced than most articles suggest.

Onset: A 2024 peer-reviewed study in the Journal of Cosmetic Dermatology found that Nabota showed faster onset than Allergan Botox, with visible effects in 85% of subjects within 2 days.

Duration: Both Allergan and Korean brands are generally reported to last 3–6 months. No published head-to-head study has demonstrated a clear, consistent duration advantage for either.

Diffusion: Slight differences in how far the toxin spreads from the injection site have been reported, which could matter for precision in small areas. This remains clinically debated.

Antibody formation: Some Korean formulations (particularly Coretox) are designed to minimize complexing proteins, which theoretically reduces the risk of developing resistance over repeated treatments. This is a reasonable theoretical argument but lacks conclusive long-term comparative data in aesthetic patients.

The bottom line: The clinical differences between Allergan Botox and well-established Korean brands like Nabota appear to be small based on available evidence. The meaningful difference for patients is regulatory status (MHLW approval vs. physician-responsibility import) and the liability pathway if something goes wrong — not a dramatic gap in how well the product works.

How to Tell Which Brand Your Clinic Uses

The simplest test: ask. Before booking, email or message the clinic with this question:

"Which brand of botulinum toxin do you use? Is it Allergan Botox Vista, or a different product?"

In Japanese: 「使用するボトックスの製剤名を教えてください。アラガンのボトックスビスタですか？」

What transparent clinics do: They list each brand separately on their pricing page with different prices. BIANCA Clinic, for example, lists Botox Vista, Coretox, and Innotox as distinct options. This is what good transparency looks like.

Red flags:

• The clinic advertises "Botox" at an unusually low price without specifying the brand.
• The clinic refuses to name the product when asked.
• The price seems too low for Allergan (anything under ¥12,000/area is almost certainly not Botox Vista).
• The English website uses "Botox" generically throughout without distinguishing brands.

Neither choice is wrong. Choosing a Korean brand to save money is perfectly reasonable if you understand what you are getting. Choosing Allergan for the regulatory reassurance is also reasonable. What matters is that the decision is yours, made with clear information.

Not sure which brand your clinic uses — or which one is right for you?

Kanbi vets every clinic in its network for brand transparency before making recommendations. When you submit a treatment request, we confirm exactly which product will be used before you book.

Submit a treatment request → kanbicare.com

Related Kanbi guides: botox clinics in Tokyo, jaw slimming botox in Tokyo, and dermal fillers in Tokyo.

FAQ

Why is some Botox so cheap in Tokyo?
Because it is not Allergan. Budget clinics use Korean-manufactured botulinum toxins (Nabota, Coretox, Botulax) that cost significantly less to acquire. These are legal and have independent safety records, but they are not MHLW-approved in Japan.

Is Korean Botox safe?
Based on available evidence, yes. Nabota holds US FDA approval (sold as Jeuveau). Clinical studies show comparable safety profiles to Allergan. However, these brands lack Japanese MHLW approval, which means manufacturer liability protections differ.

Does it matter which brand I choose?
It depends on your priorities. Clinical differences appear small. Allergan offers MHLW regulatory backing and a well-established global track record. Korean brands offer significant cost savings with reasonable safety data. Neither is wrong.

How can I verify the brand?
Ask the clinic directly before booking. Transparent clinics list brands separately on their pricing page. If a clinic will not tell you which product they use, consider that a red flag.

Is Allergan worth the extra cost?
That is a personal decision. You are paying for MHLW-approved regulatory status and the manufacturer liability that comes with it — not for a dramatically different clinical result based on current evidence.

Which brand does my Tokyo clinic use — and how do I find out?
The most reliable approach is to ask directly before your appointment. In English, ask: "Which brand of botulinum toxin do you use — Allergan Botox Vista, or a Korean brand such as Nabota or Coretox?" In Japanese, you can ask: 「ボトックスはアラガン製ですか、それとも韓国製ですか？」(Botox wa Aragan-sei desu ka, soretomo Kankoku-sei desu ka?). Clinics that are transparent will answer immediately. If a clinic is evasive or cannot answer this question, treat it as a red flag. For a list of Tokyo clinics with confirmed brand transparency, see our Botox Tokyo guide.